NEW YORK--(BUSINESS WIRE)--Alvogen, Inc., a Specialty Generics company seeking to establish a leadership position in an emerging “third” category of drugs beside branded pharmaceuticals and commoditized generics, today announced its initial product acquisition, the Today Sponge®. Utilizing a unique and challenging manufacturing process that has been significantly enhanced by Alvogen affiliate, Norwich Pharmaceuticals Inc., the Today Sponge® provides a safe and effective non-hormonal birth control alternative for millions of American women.
